A carregar...
MET Exon 14 Alterations in Lung Cancer: Exon Skipping Extends Half-Life
MET exon 14 alterations are a diverse group of mutations, many of which disrupt splice acceptor or donor sites leading to exon 14 skipping, impaired receptor degradation, and oncogenic transformation. These alterations are clinically targetable with MET-directed therapy.
Na minha lista:
| Publicado no: | Clin Cancer Res |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4911276/ https://ncbi.nlm.nih.gov/pubmed/27009743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0229 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|